These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 5628200)
1. [Ezperimental chemotherapy of Mycobacterium kansasi infection in the animal experiment]. Burjanová B; Urbancík R Beitr Klin Erforsch Tuberk Lungenkr; 1967; 135(5):364-9. PubMed ID: 5628200 [No Abstract] [Full Text] [Related]
2. Experimental chemotherapy of mycobacterioses provoked by atypical mycobacteria. Burjanová B; Urbancik R Bibl Tuberc; 1970; 26():154-88. PubMed ID: 4983240 [No Abstract] [Full Text] [Related]
3. [Isoxyl and T283 in the treatment of photochromogenic infections in mice]. Burjanová B; Dornetzhuber V Z Tuberk Erkr Thoraxorg; 1967; 127(1):123-5. PubMed ID: 5632189 [No Abstract] [Full Text] [Related]
5. Rifampicin, myambutol, Isoxyl, and capreomycin as combination partners in animal experiments. Rosenfeld M Antibiot Chemother; 1970; 16():501-15. PubMed ID: 4108897 [No Abstract] [Full Text] [Related]
6. [Infection by typical acid-fast bacteria]. Yamamoto M Naika; 1972; 29(2):281-5. PubMed ID: 4552442 [No Abstract] [Full Text] [Related]
7. [Treatment of experimental Mycobacterium kansasii infection in pneumoconiotic guinea pigs: importance of 4-4-diisoamyloxythiocardbanlide]. Tacquet A; Devulder B; Tison F; Martin JC Ann Inst Pasteur Lille; 1967; 18():95-107. PubMed ID: 5628178 [No Abstract] [Full Text] [Related]
8. The activity of various antituberculous drugs in suppressing experimental Mycobacterium leprae infection in mice. Hilson GR; Banerjee DK; Holmes IB Int J Lepr Other Mycobact Dis; 1971; 39(2):349-53. PubMed ID: 5169803 [No Abstract] [Full Text] [Related]
9. [Treatment with new antitubercular agents]. Gartmann J Dtsch Med Wochenschr; 1968 Nov; 93(47):2281-2. PubMed ID: 4301079 [No Abstract] [Full Text] [Related]
10. [Lung diseases due to atypical mycobacteria]. Favez G Schweiz Med Wochenschr; 1975 Aug; 105(31):987-91. PubMed ID: 1153999 [TBL] [Abstract][Full Text] [Related]
11. [Experimental study of 2d order tuberculostatic preparations in Mycobacterium bovis resistance to isoniazid or streptomycin (based on the data from a morphological study)]. Golyshevskaia VI; El'shanskaia MP Farmakol Toksikol; 1975; 38(2):222-4. PubMed ID: 776650 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of infections caused by atypical mycobacteria. Gialdroni-Grassi G; Grassi C Antimicrob Agents Chemother (Bethesda); 1965; 5():1074-8. PubMed ID: 5883402 [No Abstract] [Full Text] [Related]
13. New results in te chemotherapy of mycobacterioses. Rosenfeld M; Freerksen JP; Retzlaff E; Hokama S Int J Lepr Other Mycobact Dis; 1971; 39(2):358-76. PubMed ID: 5004599 [No Abstract] [Full Text] [Related]
14. [Sensitivity of Mycobacterium intracellulare and Mycobacterium kansasii to antituberculous drugs]. Zhao T; Yang SR Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Dec; 9(6):359-60, 383. PubMed ID: 3582058 [No Abstract] [Full Text] [Related]
15. Mycobacterium caprae causing lymphadenitis in a child. Bayraktar B; Togay A; Gencer H; Kockaya T; Dalgic N; Baris AB; Bulut E Pediatr Infect Dis J; 2011 Nov; 30(11):1012-3. PubMed ID: 21997664 [No Abstract] [Full Text] [Related]
16. Mycobacterium fortuitum infections: a review with two illustrative cases. Halpern AA; Nagel DA Clin Orthop Relat Res; 1978 Oct; (136):247-52. PubMed ID: 729293 [TBL] [Abstract][Full Text] [Related]
17. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria]. Saito H; Sato K; Tomioka H; Watanabe T Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537 [No Abstract] [Full Text] [Related]
18. [Tuberculosis or atypical mycobacterium]. Arbour M; L'Archevêque A Union Med Can; 1973 Oct; 102(10):2122-31. PubMed ID: 4792872 [No Abstract] [Full Text] [Related]